• Mashup Score: 0

    Patients with human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) have better responses to radiotherapy and higher overall survival rates than do patients with HPV-negative HNSCC, but the mechanisms underlying this phenomenon are unknown. p16 is used as a surrogate marker for HPV infection. Our goal was to examine the role of p16 in HPV-related favorable treatment…

    Tweet Tweets with this article
    • Previously, we linked #p16 to repression of #TRIP12 and #DDR. But the overall clinical relevance to #HNSCC as well as the how and the why remained, particularly in the context of #HPV. https://t.co/gz0uvbQwWU 2/15